Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 4 Colorectal Neoplasms 4 Colonic Neoplasms 4 Lymphatic Metastasis 2 Lung Neoplasms 2 Venous Thrombosis 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Stage IV or Unresectable Gastric Cancer 1 Rectal Neoplasms 1 Pilonidal Sinus 1 Pancreatic Neuroendocrine Tumors 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pain 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Malignant Neoplasm of Transverse Colon 1 Locally Advanced Gastric Cancer 1 Endometrial Neoplasms 1 Colorectal Liver Metastasis 1 Choledochal Cyst 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Oxaliplatin 180 Capecitabine 174 Fluorouracil 154 Radiotherapy 107 Leucovorin 107 Irinotecan 93 Bevacizumab 69 Surgical Procedures, Operative 49 Cetuximab 39 Drug Therapy 38 Radiation 35 Neoadjuvant Therapy 33 Folfox protocol 29 Chemoradiotherapy 29 XELOX 22 Magnetic Resonance Spectroscopy 21 Chemotherapy, Adjuvant 21 Radiotherapy, Intensity-Modulated 19 Surveys and Questionnaires 17 Proctectomy 16 Biopsy 16 Early Intervention, Educational 14 trifluridine tipiracil drug combination 12 Panitumumab 12 Floxuridine 12 tislelizumab 11 regorafenib 11 Nivolumab 11 Laparoscopy 11 Celecoxib 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Rectal Neoplasms × Conversion to Open Surgery × Clear all

NCT03683446 2018-09-25

NSQIPc

The Methodist Hospital Research Institute

31,795 enrolled

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡